DUBLIN--(BUSINESS WIRE)--The "Sarcopenia - Pipeline Review, H2 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.
Sarcopenia - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Sarcopenia (Musculoskeletal Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
The Sarcopenia (Musculoskeletal Disorders) pipeline guide also reviews key players involved in therapeutic development for Sarcopenia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I, Preclinical and Discovery stages are 4, 1, 7 and 3 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 1 and 2 molecules, respectively.
Sarcopenia (Musculoskeletal Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Key Topics Covered:
- Introduction
- Report Coverage
- Sarcopenia - Overview
- Sarcopenia - Therapeutics Development
- Pipeline Overview
- Pipeline by Companies
- Pipeline by Universities/Institutes
- Products under Development by Companies
- Products under Development by Universities/Institutes
- Sarcopenia - Therapeutics Assessment
- Assessment by Target
- Assessment by Mechanism of Action
- Assessment by Route of Administration
- Assessment by Molecule Type
- Sarcopenia - Companies Involved in Therapeutics Development
- Amgen Inc
- Biophytis SA
- Faraday Pharmaceuticals Inc
- GlaxoSmithKline Plc
- Immusoft Corp
- MYOS RENS Technology Inc
- Neurotune AG
- Novartis AG
- Regeneron Pharmaceuticals Inc
- ST Pharm Co., Ltd.
- Teijin Pharma Ltd
For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/bblbrc/global_sarcopenia?w=4.